News & Events about Omega Therapeutics.
Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform PR Newswire CAMBRIDGE, Mass., Oct. 17, 2022 Dr. Khrer has more than 25 years of RNA research and development experience, including pioneering novel...
Omega Therapeutics, Inc. (NASDAQ:OMGA Get Rating) Director Richard A. Young sold 10,000 shares of the companys stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $8.00, for a total value of $80,000.00. Following the completion of the ...
Flagship Pioneering Expands Leadership Team with Appointment of Michael Severino as CEO-Partner Flagship Pioneering Expands Leadership Team with Appointment of Michael Severino as CEO-Partner PR Newswire CAMBRIDGE, Mass., April 13, 2022 CAMBRIDGE, Mass., April 13, 2022 /PRNewswire/ -- Flagship...
Omega Therapeutics Presents Preclinical Data on OTX-2002, First-in-Class Epigenomic Controller, as Potential Treatment for Hepatocellular Carcinoma at the AACR Annual Meeting 2022 Omega Therapeutics Presents Preclinical Data on OTX-2002, First-in-Class Epigenomic Controller, as Potential Treatment...
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies for 2022 Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies for 2022 Ranks #2 Most Innovative Company in North America PR Newswire CAMBRIDGE, Mass., March...